Elmamoun, Musaab
Chandran, Vinod
Article History
First Online: 3 April 2018
Compliance with Ethical Standards
:
: No sources of funding were received for the preparation of this article.
: Musaab Elmamoun has no conflicts of interest directly relevant to the content of this article. Vinod Chandran reports personal fees from Amgen, grants and personal fees from Abbvie, grants and personal fees from Celgene, personal fees from Eli Lilly, personal fees from Janssen, personal fees from Novartis, personal fees from UCB, and personal fees from Pfizer within the last 3 years.